Publications and Presentations

Please note that the safety and efficacy of the agents discussed herein are under investigation and have not been established.

November 12, 2023

Novel, Potent, and Highly Selective Calcium/calmodulin-Dependent Protein Kinase II (CaMKII) Inhibitors Reduce Substrate Phosphorylation in Rat Hearts and Prolong Survival in a Mouse Model of Severe Heart Failure

Oral presentation at the American Heart Association Scientific Sessions 2023, Sunday November 12 at 4:00.

Focus: CaMKII, Heart failure

Shuichi Takagahara, Mioko Harada, Mari Asada, Masataka Harada, Masao Hirakata, Howard K. Surks, Michael E. Mendelsohn and Shota Ikeda

American Heart Association Scientific Sessions 2023